|
|
| Quarterly Results |
|
| Glenmark Pharmaceuticals Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Glenn Saldanha | | Home : Indian Private | Book Value: 651.2259081 | | BSE Code : 532296 | Market Cap: 29742.63 | | NSE Code : GLENMARK | P / E : 28.26 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 1304.16 | 2170.40 | 2098.06 | 1874.97 | | Other Income | 258.82 | 73.58 | 49.36 | 232.97 | | Total Income | 1623.91 | 2306.99 | 2193.75 | 2172.01 | | Total Expenditure | 1574.65 | 1809.60 | 1691.02 | 2379.75 | | Operating Profit | 49.26 | 497.40 | 502.73 | -207.74 | | Interest | 73.60 | 58.19 | 61.93 | 58.86 | | Gross Profit | -24.34 | 439.21 | 440.79 | -266.60 | | Depreciation | 51.16 | 49.85 | 48.75 | 46.73 | | Tax | -53.17 | 9.22 | 38.57 | 84.65 | | Deferred Tax | -1.93 | 77.80 | 81.82 | -260.51 | | Reported Profit After Tax | -20.41 | 302.35 | 271.66 | -137.47 |
|
|
|
|
|